Poison Centers have seen a nearly 1,500% increase in calls since 2019 related to overdose or side effects of injectable weight-loss drugs
This collaboration helps your team make informed decisions about medication adjustments or additional treatments
While the Bridge is an important milestone, it should also be a catalyst for creating a permanent pathway to comprehensive obesity care within Medicare and across private insurance as well." Following the announcement, Novo Nordisk says it is working with CMS, healthcare professionals, pharmacists and patient advocacy organizations to support the program's rollout
In 2014, Novo Nordisks Saxenda (liraglutide, first approved in diabetes medication Victoza) was approved for chronic weight management for obese and overweight adults
GLP-1 drugs not only have ramifications for people with obesity but also for the food industry
The engineered strain W303-1b/FGP with three biosynthetic pathways presented the highest GSH concentration (216.50 mg/L) and GSH production of W303-1b/FGP was further improved by 61.37 % when amino acid precursors (5 mM glutamic acid, 5 mM cysteine and 5 mM glycine) were fed in shake flask cultures
